General Information of the Protein
Protein ID
PT04054
Protein Name
Kallikrein-6
Secondarily
Protein Name
Neurosin
Protease M
SP59
Serine protease 18
Serine protease 9
Zyme
Gene Name
KLK6
Secondarily
Gene Name
PRSS18
PRSS9
Sequence
MKKLMVVLSLIAAAWAEEQNKLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLRQRESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSANTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Serine protease
>
Serine protease PA clan
>
Serine protease S1A subfamily
Function
Serine protease which exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. Degrades alpha-synuclein and prevents its polymerization, indicating that it may be involved in the pathogenesis of Parkinson disease and other synucleinopathies. May be involved in regulation of axon outgrowth following spinal cord injury. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis.
    Show/Hide
Uniprot ID
Primary ID:
Q92876

Secondarily ID:
A6NJA1
A8MW09
Q6H301
    Show/Hide
HGNC ID
HGNC:6367
Subcellular Location
Secreted
Nucleus
Nucleolus
Cytoplasm
Mitochondrion
Microsome
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000013 , Sf9
Compound ID Compound Name Compound Formula
CP0476159
5-[[(3S)-3-[benzyl-(7-methoxynaphthalen-2-yl)sulfonylamino]-2-oxopyrrolidin-1-yl]methyl]thiophene-2-carboximidamide
   Show/Hide
C28H28N4O4S2
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0470609
4-[[(3S)-3-[(7-methoxynaphthalen-2-yl)sulfonyl-(thiophen-3-ylmethyl)amino]-2-oxopyrrolidin-1-yl]methyl]thiophene-2-carboximidamide
   Show/Hide
C26H26N4O4S3
 1
1
IC50 = 2900 nM
   TI
   LI
   LO
   TS
CP0268912
5-[(S)-3-(7-Methoxy-naphthalene-2-sulfonylamino)-2-oxo-pyrrolidin-1-ylmethyl]-thiophene-2-carboxamidine
   Show/Hide
C21H22N4O4S2
 1
1
IC50 = 7750 nM
   TI
   LI
   LO
   TS
CP0425908
5-[[(3S)-3-[(7-methoxynaphthalen-2-yl)sulfonyl-methylamino]-2-oxopyrrolidin-1-yl]methyl]thiophene-2-carboximidamide
   Show/Hide
C22H24N4O4S2
 1
1
IC50 = 8200 nM
   TI
   LI
   LO
   TS
CP0042579
4-{[(3S)-3-[(7-methoxynaphthalene-2-)(methyl)sulfonamido]-2-oxopyrrolidin-1-yl]methyl}thiophene-2-carboximidamide
   Show/Hide
C22H24N4O4S2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0129897
5-[(S)-3-(7-Methoxy-naphthalene-2-sulfonylamino)-2-oxo-pyrrolidin-1-ylmethyl]-thiophene-3-carboxamidine
   Show/Hide
C21H22N4O4S2
 1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Kallikrein-6 (KLK6) )
Target Type Literature-reported Target